Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+100.0%
5Y CAGR+38.1%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+100.0%/yr
vs -11.1%/yr prior
5Y CAGR
+38.1%/yr
Recent acceleration
Acceleration
+111.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
5x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 504.13% |
| 2024 | -124.10% |
| 2023 | -16.47% |
| 2022 | 62.97% |
| 2021 | -19.55% |
| 2020 | 100.40% |
| 2019 | 27.16% |
| 2018 | 100.64% |
| 2017 | 226.12% |
| 2016 | 143.71% |